scholarly journals Defending scientific integrity in conservation policy processes: lessons from Canada, Australia, and the United States

2017 ◽  
Author(s):  
Carlos Carroll ◽  
Brett Hartl ◽  
Gretchen T Goldman ◽  
Daniel J Rohlf ◽  
Adrain Treves ◽  
...  
Keyword(s):  
United States ◽  
At Risk ◽  
Conflicts Of Interest ◽  
Scientific Information ◽  
The United States ◽  
Conservation Policy ◽  
Scientific Integrity ◽  
Evidence Based ◽  
Scientific Societies ◽  
Evidence Based Policy

Government agencies faced with politically controversial decisions often discount or ignore scientific information, whether from agency staff or non-governmental scientists. Recent developments in scientific integrity (the ability to perform, use, communicate and publish science free from censorship or political interference) in Canada, Australia and the United States demonstrate a similar trajectory: a perceived increase in scientific integrity abuses is followed by concerted pressure by the scientific community, leading to efforts to improve scientific integrity protections under a new administration. However, protections are often inconsistently applied, and are at risk of reversal under administrations that are publicly hostile to evidence-based policy. We compare recent challenges to scientific integrity to determine what aspects of scientific input into conservation policy are most at risk of political distortion and what can be done to strengthen safeguards against such abuses. To ensure the integrity of outbound communication from government scientists to public, we suggest that governments strengthen scientific integrity policies, include scientists’ right to speak freely in collective bargaining agreements, guarantee public access to scientific information, and strengthen agency culture supporting scientific integrity. To ensure the transparency and integrity with which information from non-governmental scientists (e.g., submitted comments or formal policy reviews) informs the policy process, we suggest that governments broaden the scope of independent reviews, ensure greater diversity of expert input with transparency regarding conflicts of interest, require substantive response to input from agencies, and engage proactively with scientific societies. For their part, scientists and scientific societies have a civic responsibility to engage with the wider public to affirm that science is a crucial resource for developing evidence-based policy and regulations that are in the public interest.

scholarly journals Defending scientific integrity in conservation policy processes: lessons from Canada, Australia, and the United States

2017 ◽  
Author(s):  
Carlos Carroll ◽  
Brett Hartl ◽  
Gretchen T Goldman ◽  
Daniel J Rohlf ◽  
Adrain Treves ◽  
...  
Keyword(s):  
United States ◽  
At Risk ◽  
Conflicts Of Interest ◽  
Scientific Information ◽  
The United States ◽  
Conservation Policy ◽  
Scientific Integrity ◽  
Evidence Based ◽  
Scientific Societies ◽  
Evidence Based Policy

Government agencies faced with politically controversial decisions often discount or ignore scientific information, whether from agency staff or non-governmental scientists. Recent developments in scientific integrity (the ability to perform, use, communicate and publish science free from censorship or political interference) in Canada, Australia and the United States demonstrate a similar trajectory: a perceived increase in scientific integrity abuses is followed by concerted pressure by the scientific community, leading to efforts to improve scientific integrity protections under a new administration. However, protections are often inconsistently applied, and are at risk of reversal under administrations that are publicly hostile to evidence-based policy. We compare recent challenges to scientific integrity to determine what aspects of scientific input into conservation policy are most at risk of political distortion and what can be done to strengthen safeguards against such abuses. To ensure the integrity of outbound communication from government scientists to public, we suggest that governments strengthen scientific integrity policies, include scientists’ right to speak freely in collective bargaining agreements, guarantee public access to scientific information, and strengthen agency culture supporting scientific integrity. To ensure the transparency and integrity with which information from non-governmental scientists (e.g., submitted comments or formal policy reviews) informs the policy process, we suggest that governments broaden the scope of independent reviews, ensure greater diversity of expert input with transparency regarding conflicts of interest, require substantive response to input from agencies, and engage proactively with scientific societies. For their part, scientists and scientific societies have a civic responsibility to engage with the wider public to affirm that science is a crucial resource for developing evidence-based policy and regulations that are in the public interest.

scholarly journals Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy

2017 ◽  
Vol Volume 10 ◽  
pp. 29-32 ◽  
Author(s):  
Jessica Keim-Malpass ◽  
Emma M Mitchell ◽  
Pamela B DeGuzman ◽  
Mark H Stoler ◽  
Christine Kennedy
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
Hpv Vaccine ◽  
The United States ◽  
Evidence Based ◽  
Evidence Based Policy ◽  
Legislative Activity

Saving Lives: Recognizing and Intervening with Youth at Risk for Suicide

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Alejandra Arango ◽  
Polly Y. Gipson ◽  
Jennifer G. Votta ◽  
Cheryl A. King
Keyword(s):  
United States ◽  
At Risk ◽  
Suicide Risk ◽  
Empirical Support ◽  
The United States ◽  
Annual Review ◽  
Publication Date ◽  
Evidence Based ◽  
Psychotherapeutic Interventions ◽  
Youth At Risk

Suicide is the second leading cause of death for youth in the United States. Fortunately, substantial advances have been achieved in identifying and intervening with youth at risk. In this review, we first focus on advances in proactive suicide risk screening and psychoeducation aimed at improving the recognition of suicide risk. These strategies have the potential to improve our ability to recognize and triage youth at risk who may otherwise be missed. We then review recent research on interventions for youth at risk. We consider a broad range of psychotherapeutic interventions, including crisis interventions in emergency care settings. Though empirical support remains limited for interventions targeting suicide risk in youth, effective and promising approaches continue to be identified. We highlight evidence-based screening and intervention approaches as well as challenges in these areas and recommendations for further investigation. Expected final online publication date for the Annual Review of Clinical Psychology, Volume 17 is May 2021. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

440: Barriers to the Practice of Evidence Based Urology in the United States

2007 ◽  
Vol 177 (4S) ◽  
pp. 147-148
Author(s):  
Philipp Dahm ◽  
Hubert R. Kuebler ◽  
Susan F. Fesperman ◽  
Roger L. Sur ◽  
Charles D. Scales ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Evidence Based

scholarly journals Food Insecurity in the United States: Identification, Treatment, and Implications

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 772-773
Author(s):  
Rose Ann DiMaria-Ghalili ◽  
Connie Bales ◽  
Julie Locher
Keyword(s):  
United States ◽  
Older Adults ◽  
At Risk ◽  
Food Insecurity ◽  
Well Being ◽  
The United States ◽  
Health Clinic ◽  
High Risk Population ◽  
Geriatric Syndrome ◽  
The Impact

Abstract Food insecurity is an under-recognized geriatric syndrome that has extensive implications in the overall health and well-being of older adults. Understanding the impact of food insecurity in older adults is a first step in identifying at-risk populations and provides a framework for potential interventions in both hospital and community-based settings. This symposium will provide an overview of current prevalence rates of food insecurity using large population-based datasets. We will present a summary indicator that expands measurement to include the functional and social support limitations (e.g., community disability, social isolation, frailty, and being homebound), which disproportionately impact older adults, and in turn their rate and experience of food insecurity and inadequate food access. We will illustrate using an example of at-risk seniors the association between sarcopenia, the age-related loss of muscle mass and function, with rates of food security in the United States. The translational aspect of the symposium will then focus on identification of psychosocial and environmental risk factors including food insecurity in older veterans preparing for surgery within the Veterans Affairs Perioperative Optimization of Senior Health clinic. Gaining insights into the importance of food insecurity will lay the foundation for an intervention for food insecurity in the deep south. Our discussant will provide an overview of the implications of these results from a public health standpoint. By highlighting the importance of food insecurity, such data can potentially become a framework to allow policy makers to expand nutritional programs as a line of defense against hunger in this high-risk population.

scholarly journals The United States’ Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research

2019 ◽  
Vol 24 (3) ◽  
pp. 147-152 ◽  
Author(s):  
Daniel Eisenman
Keyword(s):  
United States ◽  
Gene Therapy ◽  
Clinical Trials ◽  
The United States ◽  
Regulatory Environment ◽  
Evidence Based ◽  
Regulatory Structure ◽  
Regulatory Changes ◽  
Current State ◽  
Therapy Field

Introduction: A dramatic increase in the number of clinical trials involving gene-modified cell therapy and gene therapy is taking place. The field is on the verge of a boom, and the regulatory environment is evolving to accommodate the growth. Discussion: This commentary summarizes the current state of the field, including an overview of the growth. The United States (US) regulatory structure for gene therapy will be summarized, and the evolution of the oversight structure will be explained. Conclusion: The gene therapy field has recently produced its first FDA-approved therapeutics and has a pipeline of other investigational products in the final stages of clinical trials before they can be evaluated by the FDA as safe and effective therapeutics. As research continues to evolve, so must the oversight structure. Biosafety professionals and IBCs have always played key roles in contributing to the safe, evidence-based advancement of gene therapy research. With the recent regulatory changes and current surge in gene therapy research, the importance of those roles has increased dramatically.

Sign in / Sign up

Export Citation Format

Share Document